TFD10 is a glycopeptide isolated from polar cod fish that displayed inhibitory effects in prostate cancer metastasis by blocking galectin-3-mediated angiogenesis and tumor cell-endothelial cell interactions and inhibiting the apoptosis of activated T cells (291). Here, LGALS3 is linked to prostate carcinoma.